Manzil Healthcare Services measured the Life Quality Index (DLQI) of patients with immunology diseases who were in their disease management program in immunology diseases. Data were collected from 19/05/2022 to 05/06/2024.

CHRS0842024

https://doi.org/10.60840/nhrsp-5f48

This quantitative, observational, cross-sectional study was carried out in the dermatology outpatient clinics of several hospitals at Riyadh, Saudi Arabia, from May 2022 until June 2024. Data was collected using the validated Arabic version of the Dermatology of Life Quality Index (DLQI) among patients suffering from a range of dermatological diseases. Male and female patients ≥16 years were included in the dataset. A personal interview using self-administrated questionnaire were used to collect data. The questionnaire was divided into 3 sections. The first section collected demographic information, such as gender, and age. The second section gathered data on the participant’s dermatological disease, including diagnosis, bio-History, allergies, and treatment, and services provided. The third section consisted of the validated Arabic version of the DLQI.